Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Identifying missed prevention opportunities: maternal and congenital syphilis in hospital records and birth certificates in California from 2011 to 2021

Abstract

Objective

To examine maternal risk factors for congenital syphilis (CS).

Study design

We used a retrospective, population-based cohort of births in California (2011–2021) with linked birth certificates and hospital records. Modified Poisson regression models with robust standard errors were used to assess characteristics associated with CS. Among dyads with CS, maternal syphilis documentation was also examined.

Results

Of 4,481,096 births, 4659 (0.1%) had maternal syphilis without CS, and 2608 (0.06%) had both maternal syphilis and CS. CS was associated with having public insurance, tobacco use, drug use disorders, and residence in fringe-metro or medium/small-metro counties. Among CS dyads, 62.0% had no maternal syphilis documentation. There was a lower risk of no maternal syphilis documentation among those with <12th grade education; non-Hispanic Black identity; tobacco, cannabis, or drug use disorders; mental health conditions; and inadequate prenatal care.

Conclusions

Universal prenatal syphilis screening, treatment, and documentation are essential to preventing CS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Trends in maternal and congenital syphilis from 2011-2021.

Similar content being viewed by others

Data availability

Due to restrictions from the Committee for the Protection of Human Subjects (CPHS), data cannot be released by the authors. Individuals may apply for California vital statistics and California Department of Health Care Access and Information (HCAI) data directly from the Health and Human Services Agency (HHSA). Stata code used in this analysis is available upon request from the corresponding author.

References

  1. Gregory ECW, Ely DM. Trends and characteristics in maternal syphilis rates during pregnancy: United States, 2016–2022. National Center for Health Statistics, Centers for Disease Control and Prevention; 2024.

  2. David M, Hcini N, Mandelbrot L, Sibiude J, Picone O. Fetal and neonatal abnormalities due to congenital syphilis: a literature review. Prenat Diagn. 2022;42:643–55.

    Article  PubMed  Google Scholar 

  3. McClure EM, Silver RM, Kim J, Ahmed I, Kallapur M, Ghanchi N, et al. Maternal infection and stillbirth: a review. J Matern Fetal Neonatal Med. 2022;35:4442–50.

    Article  PubMed  Google Scholar 

  4. Rocha AFB, Araújo MAL, Barros VLD, Américo CF, Silva Júnior GBD. Complications, clinical manifestations of congenital syphilis, and aspects related to its prevention: an integrative review. Rev Bras Enferm. 2021;74:e20190318.

    Article  PubMed  Google Scholar 

  5. Stafford IA, Workowski KA, Bachmann LH. Syphilis complicating pregnancy and congenital syphilis. N Engl J Med. 2024;390:242–53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Chen H-Y, Klausner JD, Stafford IA. Congenital syphilis in live births: adverse outcomes, hospital length of stay, and costs. Obstet Gynecol. 2024;144:207–14.

    Article  PubMed  Google Scholar 

  7. McDonald R, O’Callaghan K, Torrone E, Barbee L, Grey J, Jackson D, et al. Vital signs: missed opportunities for preventing congenital syphilis—United States, 2022. Morb Mortal Wkly Rep. 2023;72:1269–74.

  8. Kimball A, Torrone E, Miele K, Bachmann L, Thorpe P, Weinstock H, et al. Missed opportunities for prevention of congenital syphilis—United States, 2018. Morb Mortal Wkly Rep. 2020;69:661–5.

  9. Workowski K, Bachmann L, Chan P, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70:1–187.

    Article  PubMed  PubMed Central  Google Scholar 

  10. California Department of Public Health. California sexually transmitted infections (STIs) treatment guidelines for adults and adolescents. Sacramento, CA: Sexually Transmitted Diseases Control Branch; 2025.

  11. Alexander JM, Sheffield JS, Sanchez PJ, Mayfield J, Wendel GD Jr. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol. 1999;93:5–8.

    PubMed  CAS  Google Scholar 

  12. Tannis A, Miele K, Carlson JM, O’Callaghan KP, Woodworth KR, Anderson B, et al. Syphilis treatment among people who are pregnant in six U.S. States, 2018–2021. Obstet Gynecol. 2024;143:718–29.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Machefsky AM, Loosier PS, Cramer R, Bowen VB, Kersh EN, Tao G, et al. A new call to action to combat an old nemesis: addressing rising congenital syphilis rates in the United States. J Women’s Health. 2021;30:920–6.

    Article  Google Scholar 

  14. O’Connor NP, Gonzalez BE, Esper FP, Tamburro J, Kadkhoda K, Foster CB. Congenital syphilis: missed opportunities and the case for rescreening during pregnancy and at delivery. IDCases. 2020;22:e00964.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Cooper JM, Sánchez PJ. Congenital syphilis. Semin Perinatol. 2018;42:176–84.

    Article  PubMed  Google Scholar 

  16. Fukuda A, Katz AR, Park IU, Komeya AY, Chang A, Ching N, et al. Congenital syphilis: a case report demonstrating missed opportunities for screening and inadequate treatment despite multiple health care encounters during pregnancy. Sex Transm Dis. 2021;48:e124–e5.

    Article  PubMed  Google Scholar 

  17. Smullin C, Wagman J, Mehta S, Klausner JD. A narrative review of the epidemiology of congenital syphilis in the United States from 1980 to 2019. Sex Transm Dis. 2021;48:71–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Biswas HH, Chew Ng RA, Murray EL, Chow JM, Stoltey JE, Watt JP, et al. Characteristics associated with delivery of an infant with congenital syphilis and missed opportunities for prevention-California, 2012 to 2014. Sex Transm Dis. 2018;45:435–41.

    Article  PubMed  Google Scholar 

  19. Carlson JM, Tannis A, Woodworth KR, Reynolds MR, Shinde N, Anderson B, et al. Substance use among persons with syphilis during pregnancy—Arizona and Georgia, 2018–2021. MMWR Morb Mortal Wkly Rep. 2023;72:63–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kachikis A, Schiff MA, Moore K, Chapple-McGruder T, Arluck J, Hitti J. Risk factors associated with congenital syphilis, Georgia, 2008–2015. Infect Dis Obstet Gynecol. 2023;2023:3958406.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Staneva M, Hobbs CV, Dobbs T. Spike in congenital syphilis, Mississippi, USA, 2016–2022. Emerg Infect Dis. 2023;29:1965–72.

    Article  PubMed  PubMed Central  Google Scholar 

  22. DiOrio D, Kroeger K, Ross A. Social vulnerability in congenital syphilis case mothers: qualitative assessment of cases in Indiana, 2014 to 2016. Sex Transm Dis. 2018;45:447–51.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Villarreal DD, Lewis KA, Cielo M, Klausner JD. Patterns of congenital syphilis in a large public hospital: birthing parent risk factors and infant outcomes. Sex Transm Dis. 2025;52:395-401.

  24. Daniels E, Atkinson A, Cardoza N, Ramakrishnan A, Willers D, Reno H. Social factors associated with congenital syphilis in Missouri. Clin Infect Dis. 2024;79:744–50.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Round JM, Plitt SS, Eisenbeis L, Smyczek P, Gratrix J, Charlton C, et al. Examination of Care milestones for preventing congenital syphilis transmission among syphilis-infected pregnant women in Alberta, Canada: 2017–2019. Sex Transm Dis. 2022;49:477–83.

    Article  PubMed  Google Scholar 

  26. Baer RJ, Bandoli G, Jelliffe-Pawlowski L, Chambers CD. The University of California study of outcomes in mothers and infants (a Population-Based Research Resource): retrospective cohort study. JMIR Public Health Surveill. 2024;10:e59844.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Centers for Disease Control and Prevention. National overview of STIs, 2022. Atlanta, GA: Centers for Disease Control and Prevention; 2022.

  28. Kimball A, Bowen VB, Miele K, Weinstock H, Thorpe P, Bachmann L, et al. Congenital syphilis diagnosed beyond the neonatal period in the United States: 2014–2018. Pediatrics. 2021;148:e2020049080.

  29. Centers for Disease Control and Prevention. 2013 NCHS Urban-Rural Classification Scheme for Counties. Hyattsville, MD: National Center for Health Statistics, US Department of Health and Human Services; 2014. Contract No: 166.

  30. Kotelchuck M. The adequacy of prenatal care utilization index: its us distribution and association with low birthweight. Am J Public Health. 1994;84:1486–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Chen W, Qian L, Shi J, Franklin M. Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification. BMC Med Res Methodol. 2018;18:63.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zou, G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159;702–6

  33. Goyal M, Singh P, Singh K, Shekhar S, Agrawal N, Misra S. The effect of the COVID-19 pandemic on maternal health due to delay in seeking health care: experience from a tertiary center. Int J Gynaecol Obstet. 2021;152:231–5.

    Article  PubMed  CAS  Google Scholar 

  34. Lee J. Correlates of and disparities in cancellations or delays of prenatal visits during the COVID-19 pandemic: emphasis on racial/ethnic minorities and persons with low socioeconomic status. J Racial Ethn Health Disparities. 2024;11:1564–77.

    Article  PubMed  Google Scholar 

  35. Stanford KA, Mason JA, Friedman EE. Trends in STI testing and diagnosis rates during the COVID-19 pandemic at a large urban tertiary care center, and the role of the emergency department in STI care. Front Reprod Health. 2023;5:1082429.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Hackett C, Frank L, Heldt-Werle L, Loosier PS. Provider-reported barriers in sexual health care services for women with upstream barriers: the case of syphilis and congenital syphilis in Southern Colorado, 2022. Sex Transm Dis. 2024;51:337–41.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Klaman SL, Lorvick J, Jones HE. Provision of and barriers to integrating reproductive and sexual health services for reproductive-age women in opioid treatment programs. J Addict Med. 2019;13:422–9.

    Article  PubMed  Google Scholar 

  38. Klaman SL, Turner K, Lorvick J, Jones HE. Integrating reproductive and sexual health education and services into opioid use disorder treatment programs: a qualitative study. J Addict Med. 2020;14:e175–e82.

    Article  PubMed  Google Scholar 

  39. MacAfee LK, Harfmann RF, Cannon LM, Minadeo L, Kolenic G, Kusunoki Y, et al. Substance use treatment patient and provider perspectives on accessing sexual and reproductive health services: barriers, facilitators, and the need for integration of care. Subst Use Misuse. 2020;55:95–107.

    Article  PubMed  Google Scholar 

  40. Strathdee SA, Bristow CC, Gaines T, Shoptaw S. Collateral Damage: a narrative review on epidemics of substance use disorders and their relationships to sexually transmitted infections in the United States. Sex Transm Dis. 2021;48:466–73.

    Article  PubMed  PubMed Central  Google Scholar 

  41. American College of Obstetricians and Gynecologists. Practice advisory: screening for syphilis in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2024.

  42. California Department of Public Health (CDPH) updates syphilis screening recommendations [press release]. Sacramento, CA: California Department of Public Health (CDPH); 2024.

  43. Dude AM, Drexler K, Yee LM, Badreldin N. Adherence to sexually transmitted infection screening in pregnancy. J Women’s Health. 2023;32:652–6.

    Article  Google Scholar 

  44. Asher GN, Viswanathan M, Takyi A, Middleton JC, Baker C, Kahwati LC. Screening for syphilis infection during pregnancy: updated evidence report and systematic review for the US preventive services task force. JAMA. 2025;333:2015–7.

    Article  PubMed  Google Scholar 

  45. Fang J, Silva RM, Tancredi DJ, Pinkerton KE, Sankaran D. Examining associations in congenital syphilis infection and socioeconomic factors between California’s small-to-medium and large metro counties. J Perinatol. 2022;42:1434–9.

    Article  PubMed  Google Scholar 

  46. Williams CL, Harrison LL, Llata E, Smith RA, Meites E. Sexually transmitted diseases among pregnant women: 5 States, United States, 2009–2011. Matern Child Health J. 2018;22:538–45.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Leichliter JS, Grey JA, Cuffe KM, de Voux A, Cramer R, Hexem S, et al. Geographic correlates of primary and secondary syphilis among men who have sex with men in the United States. Ann Epidemiol. 2019;32:14–9.e1.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Ahmad FA, Dickey V, Tetteh EK, Foraker R, McKay VR. The use of the consolidated framework for implementation research to understand facilitators and barriers to sexually transmitted infection screening in primary care. Sex Transm Dis. 2022;49:610–5.

    Article  PubMed  Google Scholar 

  49. Baynes A, McArthur A. Adherence to recommended Australian sexually transmitted infections screening guidelines among asymptomatic men who have sex with men: a best practice implementation project. JBI Evid Synth. 2014;12:210–26.

    Google Scholar 

  50. Cullinen K, Hill M, Anderson T, Jones V, Nelson J, Halawani M, et al. Improving sexually transmitted infection screening, testing, and treatment among people with HIV: a mixed-method needs assessment to inform a multi-site, multi-level intervention and evaluation plan. PLoS ONE. 2022;16:e0261824.

    Article  Google Scholar 

  51. Shangani S, Bhaskar N, Richmond N, Operario D, van den Berg JJ. A systematic review of early adoption of implementation science for HIV prevention or treatment in the United States. AIDS. 2021;35:177–91.

    Article  PubMed  CAS  Google Scholar 

  52. Johnson EK, Nelson CP. Values and pitfalls of the use of administrative databases for outcomes assessment. J Urol. 2013;190:17–8.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Katz A, Freier A. Recognition of inherent biases in administrative data. Can Fam Physician. 2022;68:933–4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by the Study of Outcomes of Mothers and Infants (SOMI) at the University of California San Diego. Additional support was provided by the National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) grant T32DA052142 to JF. NIH had no role in the study design, analysis, interpretation, writing, or decision to submit this study for publication.

Author information

Authors and Affiliations

Authors

Contributions

JF conceptualized the study, conducted the formal analysis, and wrote the original draft of the manuscript. RJB was responsible for data management and provided a curated dataset for the analysis. NM, RJ, and CC contributed to the conceptualization of the study, writing and interpretation of the results, and editing of the manuscript. All authors approved the final manuscript.

Corresponding author

Correspondence to Jessica Frankeberger.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

All study protocols were approved by the Committee for the Protection of Human Subjects (CPHS) within the Health and Human Services Agency (HHSA) of the State of California and the Institutional Review Board at the University of California San Diego. The study was conducted in accordance with the Declaration of Helsinki, and we received a waiver for informed consent due to the nature of the administrative dataset and minimal risk of the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frankeberger, J., Matoba, N., Baer, R.J. et al. Identifying missed prevention opportunities: maternal and congenital syphilis in hospital records and birth certificates in California from 2011 to 2021. J Perinatol (2025). https://doi.org/10.1038/s41372-025-02450-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41372-025-02450-7

Search

Quick links